NCT02527889

Brief Summary

The purpose of the study is to evaluate the effect of resistive exercise on forearm blood flow and tissue oxygenation among breast cancer survivors with or at risk for breast cancer-related lymphoedema (BCRL).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

July 16, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 19, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

March 23, 2021

Status Verified

March 1, 2021

Enrollment Period

2.1 years

First QC Date

July 16, 2015

Last Update Submit

March 22, 2021

Conditions

Keywords

Exerciseblood flow velocitytissue oxygenationBCRL

Outcome Measures

Primary Outcomes (2)

  • Brachial artery blood flow

    Measured by a Doppler ultrasonic device with a linear probe

    20 weeks

  • Tissue oxygenation

    Measured by Near-infrared spectroscopy

    20 weeks

Secondary Outcomes (6)

  • Arm circumference measurement

    20 weeks

  • Extent of lymphoedema

    20 weeks

  • Self-reported lymphoedema symptoms survey

    20 weeks

  • Hand grip strength

    20 weeks

  • Upper limb range of motion measurement

    20 weeks

  • +1 more secondary outcomes

Study Arms (2)

Exercise Group

EXPERIMENTAL

The exercise group will receive a supervised resistive exercise training. Subjects in the exercise group will attend small group-based exercise sessions twice a week for 8 weeks supervised by physiotherapists.

Other: Exercise training

Control Group

NO INTERVENTION

The control group will receive no exercise training and continue to receive standard medical care.

Interventions

8-week resistive exercise training

Exercise Group

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • female breast cancer survivors
  • remained disease free, as defined by unremarkable clinical examination within recent 6 months, with a clinical diagnosis of stable lymphoedema and without lymphedema.

You may not qualify if:

  • active breast cancer
  • have bilateral lymphedema or unstable lymphedema
  • have musculoskeletal, cardiovascular and/ or neurological disorders that could inhibit them from exercising.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hong Kong Polytechnic University

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

LymphedemaBreast NeoplasmsMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic DiseasesNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate

Study Record Dates

First Submitted

July 16, 2015

First Posted

August 19, 2015

Study Start

July 1, 2015

Primary Completion

August 1, 2017

Study Completion

August 1, 2017

Last Updated

March 23, 2021

Record last verified: 2021-03

Locations